What you should know:
1. If completed, the transaction will be Blackstone’s first in the Japanese market.
2. The transaction could close in the second quarter of 2019.
3. Ayumi’s flagship product Calonal is a leading acetaminophen drug used to treat chronic pain.
4. Ayumi also has a comprehensive synthetic and biosimilar product portfolio.
More articles on devices:
AAOS names Dr. Joseph Bosco III 1st vice president — 4 insights
5 insights into new AAHKS President Dr. Michael Bolognesi
HSS surgeon-in-chief emeritus makes $35k donation to high school
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
